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Abstract
Background: Inflammation is commonly followed by the release of endogenous proteins called danger associated
molecular patterns (DAMPs) that are able to warn the host for eminent danger. S100A8/A9 subunits are DAMPs that belong
to the S100 family of calcium binding proteins. S100A8/A9 complexes induce an inflammatory response and their
expression correlates with disease severity in several inflammatory disorders. S100A8/A9 promote endotoxin- and
Escherichia (E.) coli-induced sepsis showing its contribution in systemic infection. The role of S100A8/A9 during a local
infection of the urinary tract system caused by E. coli remains unknown.
Methodology/Principal Findings: We investigated the contribution of S100A8/A9 in acute urinary tract infection (UTI) by
instilling 2 different doses of uropathogenic E. coli transurethrally in wild type (WT) and S100A9 knockout (KO) mice.
Subsequently, we determined bacterial outgrowth, neutrophilic infiltrate and inflammatory mediators in bladder and kidney
24 and 48 hours later. UTI resulted in a substantial increase of S100A8/A9 protein in bladder and kidney tissue of WT mice.
S100A9 KO mice displayed similar bacterial load in bladder or kidney homogenate compared to WT mice using 2 different
doses at 2 different time points. S100A9 deficiency had little effect on the inflammatory responses to E. Coli-induced UTI
infection, as assessed by myeloperoxidase activity in bladder and kidneys, histopathologic analysis, and renal and bladder
cytokine concentrations.
Conclusions: We show that despite high S100A8/A9 expression in bladder and kidney tissue upon UTI, S100A8/A9 does not
contribute to an effective host response against E. Coli in the urinary tract system.
Citation: Dessing MC, Butter LM, Teske GJ, Claessen N, van der Loos CM, et al. (2010) S100A8/A9 Is Not Involved in Host Defense against Murine Urinary Tract
Infection. PLoS ONE 5(10): e13394. doi:10.1371/journal.pone.0013394
Editor: Jo ¨rg Hermann Fritz, University of Toronto, Canada
Received March 23, 2010; Accepted September 20, 2010; Published October 14, 2010
Copyright:  2010 Dessing et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study has been financially supported by the Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: m.c.dessing@amc.uva.nl
Introduction
Most cases of ‘‘community-acquired’’ urinary tract infection
(UTI) are due to enteric bacteria that enter the urinary tract, of
which Escherichia (E.) coli is the most common organism (70–80%).
UTI is a very frequent infection, affecting 12/10000 woman and
4/10000 men annually [1]. In the United States alone, the
estimated annual societal cost of UTI is more than 3 billion dollars
[2]. Moreover, UTI frequently occurs during childhood and may
cause inflammation of the renal pelvis (pyelonephritis), which is a
major factor in the development of end stage renal failure in
children and young adults [3,4]. Unfortunately, no licensed
vaccine to prevent UTI exists, therefore unraveling the molecular
mechanisms behind pathogen-host interaction is required for
successful vaccine development. Bladder epithelial cells play an
important part in the innate immune response during UTI
because they express several Toll-like receptors (TLR), pattern
recognition receptors which recognize motifs expressed by
pathogens to induce an inflammatory response [5]. TLRs
contribute to innate immune activation in the settings of both
infection and sterile injury by responding to a variety of microbial,
but also to endogenous proteins called danger associated
molecular patterns (DAMPs) like heat shock proteins, high
mobility group box chromosomal protein 1, heparan sulfate,
hyaluronan fragments, and fibronectin [5,6]. Although the
manner by which pathogen-host interaction occurs during E.coli-
induced UTI is slowly beginning to unravel [7], the contribution of
DAMPs released upon inflammation is less clear. One group of the
identified DAMPs are S100 proteins which mediate an inflam-
matory response and are involved in the recruitment of
inflammatory cells to the site of infection [8,9]. Of particular
interest are S100A8 (myeloid-related protein MRP8; calgranulin
A) and S100A9 (MRP14; calgranulin B). S100A8 and S100A9
form heterodimers, which are the biologically relevant forms of
these proteins and have pleiotropic properties [9,10,11]. S100A8/
A9 are found in granulocytes, monocytes and early differentiation
stages of macrophages and can be induced in keratinocytes and
epithelial cells under inflammatory conditions [9,10]. S100A8 is
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S100A9 KO mice despite normal S100A8 mRNA levels, probably
due to the elevated metabolism of S100A8 in the absence of its
binding partner. Thus, targeted deletion of S100A9 leads to a
complete lack of a functional S100A8/A9 complex in the mouse
[12,13]. In contrast to S100A8 KO mice, S100A9 KO mice are
viable and in addition, lack the functional S100A8/A9 protein
complex [13,14]. Interestingly, S100A8/A9 protein complex
interacts with TLR4 [12] and the extent of S100A8/A9 expression
correlates with disease activity in several inflammatory disorders
[9,10,15,16]. So far, the knowledge about the contribution of
S100A8/A9 during (urinary tract) infection is limited. Reyes et al.
showed that Ureaplasma parvum-induced UTI lead to increased
S100A8/A9 expression in bladder tissue however, its contribution
was not further investigated [17]. Previously it was shown that
S100A9 KO mice were protected against mortality induced by
endotoxic shock and E.coli induced sepsis suggesting a detrimental
role during systemic inflammation and infection [12]. This shows
the contribution of S100A8/A9 in systemic infection, however its
contribution in local infection is unknown. Therefore, we
investigated the expression, localization and contribution of
S100A8/A9 during E. coli-induced UTI.
Materials and Methods
Mice
Deletion of the MRP8/S100A8 gene in mice results in an
embryonic lethal phenotype [18]. Therefore we used MRP14/
S100A9 knockout (KO) mice which lack biological active
S100A8/A9 protein complex [13,14]. S100A9 KO mice were
generated by target gene disruption of the Mrp14 gene as described
[13] and are backcrossed six times to a C57BL/6 background.
Pathogen-free 9- to 10-week-old female C57BL/6 wild-type (WT)
mice were purchased from Charles River Laboratories. Age-
matched mice were used in all experiments. All mice were bred in
the animal facility of the Academic Medical Center in Amsterdam,
The Netherlands. The Animal Care and Use Committee of the
University of Amsterdam approved all experiments.
Urinary tract infection
Urinary tract infection (UTI) was induced as described earlier
[19,20,21]. Briefly, E. coli 1677, an isolation from a patient with
urinary tract infection, was grown overnight in Tryptone Soy
Broth (TSB) medium at 37uC. The next day, a 1:100 dilution in
fresh TSB medium was grown until logarithmic phase, spun down
and washed twice with cold phosphate-buffered saline (PBS). E. coli
was resuspended in PBS and 10-fold serial dilutions were plated
and grown on blood-agar plates overnight at 37uC to determine
concentration. UTI was induced under general anesthesia with
0.07 mL/10 g mouse of FFM mixture, containing 1.25 mg/mL
midazolam (Roche, Mijdrecht, The Netherlands), 0.08 mg/mL
fentanyl citrate and 2.5 mg/mL fluanisone (Janssen Pharmaceu-
tica, Beerse, Belgium). Hundred ml of bacterial suspension (total
4.5610
8 or 9.0610
8 colony forming units -CFUs-) was adminis-
tered transurethrally through a 0.55 mm catheter (Abbott, Zwolle,
The Netherlands). Mice were sacrificed 24 or 48 hours after the
induction of UTI. Sham control mice underwent the same
procedure with administration of 100 mL of sterile PBS and were
sacrificed the following day.
Bacterial outgrowth
Mice were anesthetized and heparin-blood and kidneys were
collected. The left kidney from each mouse was weighted and
homogenized in 4 volumes of sterile saline using a tissue
homogenizer to correct for differences in weight (Polytron
PT1300D homogenizer, Kinematica AG). The homogenizer was
cleaned with 70% ethanol after each homogenization. The
bladder from each mouse was homogenized in 9-fold volumes of
saline. Serial 10-fold dilutions were made in sterile saline and
50 mL volumes of kidney homogenate, bladder homogenate and
blood were plated onto blood agar plates, which were incubated at
37uC for 16 h, after which E. coli CFUs were counted. CFU count
in urine was not performed due to technical difficulty; mice with
UTI void their bladder more frequently making urine collection
difficult.
Preparation of tissue for ELISA measurements
For ELISA measurements, kidney homogenates were
diluted 1:2 in lysis buffer. (300 mM NaCl, 30 mM Tris,
2 mM MgCl2, 2 mM CaCl2, 1% Triton X-100, pepstatin A,
leupeptin, and aprotinin, all 20 ng/ml; pH 7.4) and incubated at
4uC for 30 min. Homogenates were centrifuged at 1500 g and
4uC for 15 min, and supernatants were stored at 280uC until
assays were performed. S100A8/A9 ELISA was performed
as described earlier [12]. Tumor necrosis factor (TNF)-a,
macrophage inflammatory protein (MIP)-2 and keratinocyte-
derived chemokine (KC) were measured in kidney homogenate
using specific ELISAs (R&D Systems) according to manufacturer
instructions. Myeloperoxidase (MPO) was measured by ELISA
(HyCult, Uden, the Netherlands).
White blood cell count
White blood cell (WBC) counts in peripheral blood were
determined using a hemocytometer (Beckman Coulter, Fullerton,
CA, USA). For differentiation: 5 ml of whole blood was used for
blood smear and stained with Giemsa (Diff-Quick; Baxter,
McGraw Park, Il). Two-hundred to 250 WBC were counted at
high power fields (magnification 400x) after which percentage of
different cell types were determined.
Immunohistochemistry
Right mouse kidney tissue samples were fixed in 4% formalin
and processed to paraffin blocks. Four-micrometer sections were
cut, mounted on coated slides and dried overnight at 37uC. After
dewaxing and rehydration, heat-induced epitope retrieval (HIER)
was performed by boiling tissue samples for 10 minutes in citrate
buffer (pH 6.0). Immunohistochemical sequential double alkaline
phosphatase (AP) staining was performed essentially as previously
described [22]. Briefly, for granulocyte/S100A8-A9 double
staining, sections were incubated overnight at 4uC with rat-anti-
muis-Ly6G-FITC (BD Pharmingen, Erembodegem, Belgium)
followed by rabbit anti-FITC antibody (Dako, Glostup, Denmark).
For macrophage/S100A8-A9 double staining, sections were
incubated with rabbit anti-rat F4/80. All slides were subsequently
incubated with PowerVision anti-rabbit AP (ImmunoLogic,
Duiven, The Netherlands). AP activity was visualized in blue,
using Vector Blue (Vector Labs, Burlingame, CA, USA). Next, a
second HIER step was applied to remove the antibodies from the
first staining sequence, but leaving the deposits of blue reaction
product unchanged [22]. Sections were incubated with rat-anti-
mouse S100A8 or S100A9 (R&D systems, Abingdon, United
Kingdom) for 3 hours followed by goat-anti-rat IgG AP. AP
activity was visualized in red using Vector Red (Vector Labs).
Antibodies were diluted in Antibody Diluent (ImmunoLogic,
Duiven, The Netherlands). Spectral imaging was used to analyze
colocalization of S100A8/A9 and with Ly6G or F4/80. Specimens
were observed with a Leica BM15000 microscope (Leica
Microsystems, Wetzlar, Germany) and analyzed with Nuance
S100A8/A9 and Infection
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Instrumentation, Woburn, MA) with Nuance software version
2.10. Spectral data sets and spectral libraries of Vector Blue and
Vector Red were acquired from 440–720 nm at 20 nm intervals
[22,23]. Single Ly6G staining was performed as described earlier
[24].
Statistical analysis
All data are presented as mean 6 standard error of the mean
(SEM) unless mentioned otherwise. Data were analyzed by the
Mann–Whitney U-test. Difference in positive blood culture
between groups was analyzed by Chi-square test. P,0.05 was
considered to represent a statistically significant difference.
Results
S100A8/A9 expression and localization
First, we determined S100A8/A9 protein complex expression in
bladder and kidney tissue from WT mice upon UTI induced by
9610
8 CFU/mouse. As shown in figure 1A–B, S100A8/A9 level
was higher in bladder and kidney homogenates from WT mice 24
and 48 hours after induction of UTI compared to sham mice.
S100A8/A9 protein expression was undetectable in kidney and
bladder homogenate from naı ¨ve- or infected S100A9 KO mice
(data not shown). To determine the localization and source of
S100A8/A9 protein expression in kidney tissue, we performed
double staining for S100A8/A9 with Ly6G (a marker for
granulocytes) or with F4/80 (a marker for macrophages). Naı ¨ve
WT mice displayed very few Ly6G, F4/80 or S100A8/A9 positive
cells (Figure 1C and data not shown). Next, we performed double
staining for Ly6G with S100A9 to study colocalization in kidney
tissue slides obtained from WT mice, 24 hours after infection
(Figure 1D–F). Figure 1D shows double AP staining indicating
colocalization of Ly6G and S100A9. Using spectral imaging we
could distinguish Ly6G positive cells (Vector Blue, figure 1E) from
S100A9 positive cells (Vector Red, figure 1F). Double staining with
Ly6G and S100A8 displayed similar patterns in kidney tissue slides
as observed with Ly6G/S100A9 double staining (data not shown).
F4/80-S100A9 double staining was absent in renal tissue slides
obtained from WT mice 24 hours after infection (data not shown).
As a control, S100A9 staining was absent in renal tissue slides
obtainedfromS100A9KOmice subjectedtoUTI(datanotshown).
Bacterial outgrowth
S100A8/A9 is considered to have antimicrobial properties
[25,26,27,28,29,30,31,32,33,34]. To establish the role of S100A8/
Figure 1. Expression and localization of S100A8/A9 during UTI. S100A8/A9 protein expression in bladder (1A) and kidney (1B) homogenate
from sham WT mice (white bar) and from WT mice 24 and 48 hours after UTI with 9610
8 E. coli CFU/mouse (black bars). Data are mean 6 SEM; N=7–
8 mice per group, *P,0.05, **P,0.005 versus sham, #P,0.005 versus 24 hours UTI. Sequential double AP staining using Ly6G (indicating
granulocyte staining) and S100A9 antibodies on kidney tissue from sham WT mice (1C) or WT mice 24 hours after UTI with 9610
8 E. coli CFU (1D–F).
Using spectral imaging Ly6G/S100A9 double staining was separately visualized for Ly6G (Vector Blue, 1E) or S100A9 (Vector Red, 1F). Scale bars
display 0.1 mm.
doi:10.1371/journal.pone.0013394.g001
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(figure 2C+D) homogenates from WT mice (black squares) and S100A9 KO mice (white squares), 24 and 48 hours after inoculation with 4.5610
8 or
9.0610
8 CFU E. coli/mouse. Single experimental data are depicted as individual squares, lines represent median. N=6–9 mice per group.
doi:10.1371/journal.pone.0013394.g002
Figure 3. Contribution of S100A8/A9 to neutrophil influx during UTI. Granulocyte influx (as reflected by MPO levels) in bladder (figure 3A+B)
and kidney (figure 3C+D) homogenates from WT mice (black squares) and S100A9 KO mice (white squares), 24 and 48 hours after inoculation with
4.5610
8 or 9.0610
8 CFU E. coli/mouse. Single experimental data are depicted as individual squares, lines represent median. N=6–9 mice per group,
*P,0.05 vs. WT mice. Representative picture of Ly6G staining from renal tissue slides obtained from WT mice (1E) and S100A9 KO mice (1F), 48 hours
after infection with 4.5610
8 CFU E. coli/mouse. In S100A9 KO mice, more granulocytes were observed, especially in the renal pelvis (indicated by
asterisk). Scale bars display 0.1 mm.
doi:10.1371/journal.pone.0013394.g003
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by instilling transurethrally 9610
8 CFU E. coli. Twenty-four and
48 hours thereafter, WT and S100A9 KO mice displayed similar
bacterial loads in bladder and kidney homogenates (figure 2A+C).
Dissemination of E. coli from the urinary tract to the circulation
was not significantly different between WT and S100A9 KO mice
24 and 48 hours after infection (number of positive blood cultures;
WT vs. S100A9 KO mice, t=24: 0/9 vs. 3/9, P=0.06 and t=48:
0/9 vs. 0/9, P=1.00). As S100A8/A9 might play a role during a
less severe infection, we infected WT and S100A9 KO mice with
4.5610
8 CFU/mouse. Again, similar bacterial loads in the
bladder and kidney were observed in WT and S100A9 KO mice
24 and 48 hours after infection (figure 2B+D). Dissemination of E.
coli from the uropathogenic tract to the circulation was also
undistinguishable in WT and S100A9 KO mice 24 and 48 hours
after infection with 4.5610
8 CFU (number of positive blood
cultures; WT vs. S100A9 KO mice, t=24: 1/7 vs. 0/8, P=0.27
and t=48: 0/6 vs. 1/7, P=0.34).
Leukocyte recruitment
An essential part of the host defense against invading pathogens
is the recruitment of neutrophils to the site of infection. Besides
antimicrobial properties, S100A8/A9 has chemo-attractant prop-
erties [35,36,37,38,39]. We therefore determined levels of MPO to
quantify neutrophil influx in both bladder and kidney homoge-
nates (figure 3). MPO levels in bladder and kidney homogenate
from sham mice were similar between WT and S100A9 KO
mice (bladder: WT vs. S100A9 KO mice 0.2160.03 vs. 0.386
0.15 ng/g tissue; kidney: WT vs. S100A9 KO mice 0.7460.04 vs.
1.1860.12 ng/g tissue, data are mean 6 SEM, N=7–8). Except
for higher renal MPO level in S100A9 KO mice, 48 hours after
instilling 4.5610
8 CFU (figure 3D), no differences in MPO level in
bladder and kidney homogenate were observed between WT and
S100A9 KO mice. The higher MPO level in S100A9 KO mice
mentioned above was confirmed by Ly6G staining on renal tissue
slides from WT and S100A9 KO mice, 48 hours after instilling
4.5x10
8 CFU showing that S100A9 KO mice displayed more
granulocytes in renal tissue, especially in renal pelvis (figure 3E+F).
WBC counts and differentials in blood were similar in uninfected
WT and S100A9 KO mice, as well as in infected WT and S100A9
KO mice at both time points using 2 different doses of E. coli
(Table 1).
Inflammatory mediators
Cytokines and chemokines play an important role in an
adequate antibacterial defense. To determine whether S100A8/
A9 deficiency affected production of inflammatory mediators, KC,
MIP-2 and TNF-a were determined in bladder and kidney
homogenates (figure 4). There were hardly any significant
differences in cytokine and chemokine levels between WT and
S100A9 KO mice. We only found significantly reduced KC and
MIP-2 levels in bladder homogenates from S100A9 KO mice,
respectively 24 hours after infection with 9610
8 CFU and
48 hours after infection with 4.5610
8 CFU. In kidney homoge-
nates, only TNF-a levels were significantly reduced in S100A9
KO mice, 24 hours after infection with 4.5610
8 CFU.
Discussion
UTI caused by uropathogenic E.coli is a substantial economical
and social burden. Left untreated UTI can lead to pyelonephritis
with increasing risk of permanent renal scarring and bacteremia.
During inflammation, several DAMPs may be released by
damaged host cells which can trigger the immune system to
improve the clearance of infection or can contribute to
inflammation-induced collateral tissue damage. One of these
DAMPs, S100A8/A9 is highly expressed in bladder during
complicated U. parvum-induced experimental UTI [17] and in
serum of patients with sepsis caused by UTI [40]. Recently it was
shown that S100A9 KO mice were protected against mortality
during E. coli-induced sepsis[12] showing its contribution in
systemic infection. This study is the first to investigate the
expression, localization, and role of S100A9 in a local E. coli-
induced infection of the urinary tract system. High levels of
S100A8/A9 were observed in bladder and kidney tissue during
UTI. To study the contribution of S100A8/A9 protein complex in
vivo during UTI we used S100A9 KO mice which lack the
functional S100A8/A9 protein complex. We found that the
Table 1. White blood cell composition and total white blood cell count in blood from WT and S100A9 KO mice.
Sham Mono (%) Lympho (%) Gran (%) TCC (x 10
6)
T24 WT 0.660.2 89.561.3 10.061.1 2.960.5
S100A9 KO 0.760.2 88.662.1 10.762.1 4.060.7
9610
8 CFU Mono (%) Lympho (%) Gran (%) TCC (x 10
6)
T24 WT 0.960.4 77.265.0 21.964.8 2.960.6
S100A9 KO 1.060.4 73.065.4 25.965.2 4.060.7
T48 WT 0.660.2 76.562.7 22.962.7 5.760.8
S100A9 KO 0.660.3 81.762.1 17.762.1 8.461.0
4.5610
8 CFU Mono (%) Lympho (%) Gran (%) TCC (x 10
6)
T24 WT 1.660.3 82.062.8 16.362.6 10.861.3
S100A9 KO 0.760.3 86.862.7 12.562.6 13.562.3
T48 WT 0.460.2 88.061.8 11.661.9 5.460.3
S100A9 KO 0.560.1 84.163.1 15.463.2 4.560.7
Whitebloodcellcomposition and totalcellcountin blood from WT and S100A9 KO mice, 24 and 48 hours after instillation with 9610
8 CFU uropathogenic E. coli/mouse or
4.5610
8 CFU/mouse. Sham mice were sacrificed 24 hours after inoculation with sterile PBS. Monocytes (mono), lymphocytes (lympho) and granulocytes (gran) are
expressed as percentage of white blood cells. Total cell count (TCC) is presented as amount of white blood cells per ml. Data are mean 6 SEM. (N=6–8 per group).
doi:10.1371/journal.pone.0013394.t001
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mice was not significantly different from WT mice using 2
different bacterial doses at 2 different time points after infection.
Moreover, S100A8/9 deficiency had little or no effect on the
inflammatory response to E. Coli-induced UTI infection, as
assessed by myeloperoxidase activity in bladder and kidneys,
histopathologic analysis, and renal and bladder cytokine concen-
trations. In conclusion, S100A8/A9 deficiency did not influence
the host response after infection with two doses of uropathogenic
E. Coli, suggesting that endogenous S100A8/A9 does not play a
major role in the pathogenesis of E. Coli-induced UTI.
Recently it has become clear that infection is commonly related
to the release of DAMPs that serve to warn the host for eminent
danger. S100 proteins have been suggested as DAMPs [12]. Of
these S100 proteins, S100A8/A9 are of special interest because
S100A8/A9 complexes induce an inflammatory response and
S100A8/A9 expression correlates with disease severity in several
inflammatory disorders [9,15]. The expression of S100A8/A9 has
been investigated in several infection models. S100A8/A9 levels
were higher in lung tissue and bronchoalveolar lavage fluid during
pneumococcal pneumonia in mice [39]. In addition, U. parvum-
induced complicated UTI in rats, leads to higher expression of
S100A8/A9 complex in bladder tissue compared to bladders from
animals with asymptomatic UTI [17]. These data are in line with
our results demonstrating that during UTI, levels of S100A8/A9
increased in both bladder and kidney homogenates. We anticipate
that the S100A8/A9 expression we found originated from
infiltrating granulocytes at infected areas. First, S100A8/A9 is
the most abundant protein present in granulocytes [41]. Secondly,
we found a strong colocalization of S100A8/A9 with granulocytes,
but not with macrophages.
S100A8/A9 complexes 44also have antimicrobial properties
[25,26,27,28,29,30,31,32,33,34]. We however did not observe
differences in bacterial outgrowth in kidney and bladder homogenate
between WT and S100A9 KO mice at two different time points using
two different doses of E. coli. In line with these results, Raquil et al.
showed that pretreatment of mice with S100A8 and S100A9
antibodies, alone or in combination, had no effect on the bacterial
load during pneumococcal pneumonia [39]. Our data suggests that
during UTI, the lack of S100A8/A9 may be compensated for by
other mediators. The previous study [39] and our data oppose a role
for S100A8/A9 in antibacterial defense mechanism.
Figure 4. Contribution of S100A8/A9 to cytokine and chemokine production during UTI. Chemokine and cytokine levels (KC, MIP-2 and
TNF-a) in bladder (figure 4A–C) and kidney (figure 4D–F) homogenates from WT mice (black squares) and S100A9 KO mice (white squares), 24 and
48 hours after inoculation with 4.5610
8 or 9.0610
8 CFU E. coli/mouse. Sham mice were sacrificed 24 hours after inoculation with sterile PBS. Single
experimental data are mean 6 SEM. N=6–9 mice per group, *P,0.05 vs. WT mice.
doi:10.1371/journal.pone.0013394.g004
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[35,36,37,38,39]. Blocking S100A8/A9 inhibits neutrophil migration
in response to LPS [42]. In addition, migration of granulocytes and
macrophages to the alveoli was diminished during pneumococcal
pneumonia when mice were treated with S100A8/A9 antibodies
[39]. Expect for one particular time-point and E.coli dose in renal
tissue, we observed no consistent difference in granulocyte influx in
bladder and kidney tissue between infected S100A9 KO and WT
mice. Our data argue against the specific chemoattractant properties
of S100A8/A9 during E. Coli-induced UTI. Similar, except for
several small differences in inflammatory mediators in kidney or
bladder tissue between WT and S100A9 KO mice, we also did not
observe large differences in production of inflammatory mediators.
Recently, the contribution of S100A8/A9 protein complex
during infection has been appreciate again due to its pro-
inflammatory properties and interaction with TLR4. So far, little
is known about its expression, localization and contribution during
infection in vivo. The novel S100A9 KO mice are a valuable tool in
this research area. This study is the first to describe the
contribution of S100A8/A9 during (E.coli-induced) UTI using
S100A9 KO mice. We show that despite high S100A8/A9
expression in bladder and kidney tissue upon UTI, in this model
S100A8/A9 does not contribute to an effective host response
against E. Coli in the urinary tract system.
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